Cancer of Rectum: Clinical Trials

3 trials for Cancer of Rectum, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 terminated. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 2, Terminated 1
Phase 23Unknown 2, Terminated 1

Follow Cancer of Rectum: new trials by email Literature Review of Cancer of Rectum trials Research Report on Cancer of Rectum

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Cannabidiol, Bortezomib, Leucovorin - Cancer of Pancreas, Cancer of Liver
Phase 1 / Phase 2UnknownLeaf Vertical Inc.1602019-01-152018-07-31
Fluorescence Targeted Pelvic Lymph Node Mapping
Indocyanine Green - Cancer of Rectum, Lymph Node Disease
Phase 1 / Phase 2TerminatedOxford University Hospitals NHS Trust12017-08-012019-08-13
Study to Nivolumab Following Preoperative Chemoradiotherapy
Nivolumab, Ipilimumab - Cancer of Rectum
Phase 1 / Phase 2UnknownTakayuki Yoshino902016-10-012021-09-16

Narrower conditions

Rectal Neoplasms (3)  ·  Colonic Neoplasms (1)  ·  Gallbladder Neoplasms (1)  ·  Glioblastoma (1)  ·  Liver Neoplasms (1)  ·  Multiple Myeloma (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Colorectal Neoplasms (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Gastrointestinal Diseases (3)  ·  Gastrointestinal Neoplasms (3)  ·  Intestinal Diseases (3)  ·  Intestinal Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Rectal Diseases (3)  ·  Astrocytoma (1)  ·  Biliary Tract Diseases (1)  ·  Biliary Tract Neoplasms (1)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)

Interventions

Bevacizumab (1)  ·  Bortezomib (1)  ·  Cannabidiol (1)  ·  Capecitabine (1)  ·  Chemoradiotherapy (1)  ·  Fluorouracil (1)  ·  Gemcitabine (1)  ·  Indocyanine Green (1)  ·  Ipilimumab (1)  ·  Irinotecan (1)  ·  Leucovorin (1)  ·  Nivolumab (1)  ·  Oxaliplatin (1)  ·  Temozolomide (1)

Sponsors

Leaf Vertical Inc. (1)  ·  Oxford University Hospitals NHS Trust (1)  ·  Takayuki Yoshino (1)

Countries

Japan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Chris Cunningham, MD (1)  ·  Sarah F Katta, DO (1)  ·  Takayuki Yoshino, Dr (1)  ·  Thomas Barnes, MBChB (1)

Results publications

PMID 38834744